Establishment Labs Holdings Inc（ESTA）の株式分析ESTAEstablishment Labs Holdings Inc

Establishment Labs Holdings Inc. is Costa Rica-based medical technology and aesthetics company that is focused on women's health reconstruction market. The Company is engaged in the designing, developing, manufacturing and marketing of product portfolio consisting of silicone-filled breast and body shaping implants. The main activities are conducted at two manufacturing facilities in Costa Rica including Motiva Implants brand sold in over 80 countries globally through a combination of distributors and direct sales to customers. It operates in the Healthcare sector (ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUP industry).

Establishment Labs Holdings Inc is currently a hold. The stock is priced at $70.64, significantly below analyst price targets of $92 and $105, indicating potential upside. However, the RSI is at a low 23.939, suggesting the stock is oversold, which could lead to further declines in the short term. The company reported a strong Q2 2026 revenue of $67.5 million, a 31.7% year-over-year increase, but remains unprofitable with a net income loss of $11.7 million in Q2 2026. The main risk is the high insider selling activity, which has increased by 141.15% over the last month, indicating potential lack of confidence from insiders.

3 analysts cover ESTA: 3 rate it Buy, 0 Hold and 0 Sell. The average price target is 82.88.